Index
-
68
-
69/70/71
-
72/73
-
74/75
-
76/77
-
78
-
79
-
80
FIGURE 3: PROPOSED OPTIMAL DURATION OF HCV THERAPY IN HCV/HIV CO-INFECTED PATIENTS
a)
In patients with baseline low viral load (<400 000 IU/ml) and minimal liver fibrosis.
